Research
Impact of Comorbid Depression and Anxiety on the Mortality among Adults with Cardiometabolic Diseases
Nature · By Shuzhen Liu ·
The Brief
- A study in Nature Communications, published online on 18 November 2026, examines how comorbid depression and anxiety relate to mortality among adults with cardiometabolic diseases.
- Cardiometabolic diseases often coexist with depression or anxiety, but the prognostic implications of this coexistence have been unclear.
- The source excerpt is truncated, so the study's specific findings are not reported here.
Why it matters
Depression and anxiety are common alongside cardiometabolic conditions, so evidence on whether they change survival could inform how clinicians assess and manage patients with these conditions.
Who’s affected
- clinicians and researchers in cardiometabolic and mental health
- adults living with cardiometabolic diseases
- #cardiometabolic disease
- #depression
- #anxiety
- #mortality
- #comorbidity
Nature Communications, Published online: 18 November 2026; doi:10.1038/s41467-026-79803-z Cardiometabolic diseases often coexist with depression or anxiety, but their prognostic implications remain unclear. Here, the authors show that depression/anxiety after cardiometabolic…